• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

University of Colorado Boulder

Headquarters: Boulder, CO, United States
Website: http://www.colorado.edu
Year Founded: 1876
Status: N/A

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Dec 11, 2020
Emerging Company Profile

Launching with $81M, Third Rock’s Faze is latest biotech seeking to unravel biomolecular condensates biology

Emerging Company Profile: dissecting normal and pathogenic biomolecular condensate biology to enable drug development
Read More
BioCentury | Aug 8, 2020
Product Development

Asymptomatic COVID-19 testing pushes forward, with lessons from cancer

As broad COVID-19 screening gains momentum, early cancer detection provides a playbook
Read More
BioCentury | Sep 26, 2019
Emerging Company Profile

Edgewise: breaking away from dystrophin for muscular dystrophy

Edgewise emerges from stealth with $50M series B, dystrophin-independent muscle-stabilizing compounds
Read More
BioCentury | Jul 19, 2019
Regulation

A half step forward for heart failure as FDA guidance leaves key question unanswered

FDA will need to nail down details in its heart failure guidance to really boost investment
Read More
BioCentury | Jun 11, 2019
Distillery Therapeutics

CARD11, MALT1 inhibition sensitizes melanoma, colorectal tumors to PD-1 inhibitors

Read More
BioCentury | Oct 31, 2017
Distillery Therapeutics

Infectious disease

Read More
BioCentury | Mar 24, 2017
Strategy

Change from within

NIH insiders have their own proposals for reform
Read More
BioCentury | Feb 28, 2017
Clinical News

Caltech group finds proteasome inhibitor with novel MOA

Read More
BioCentury | Aug 18, 2016
Distillery Therapeutics

Therapeutics: High mobility group box 1 (HMGB1)

Read More
BioCentury | Aug 11, 2016
Targets & Mechanisms

Niche for the aged

Targeting integrin β1 or fibronectin for muscle repair in the aged
Read More
Items per page:
1 - 10 of 39